DermaSensor adds $4M Series B extension, reaching $48M total funding
DermaSensor raised a $4 million Series B extension in September, bringing cumulative funding to $48 million; backers were not disclosed.
The company plans commercial infrastructure for nationwide device access and faster growth.
The extension supports scaling its handheld skin-lesion assessment device to healthcare professionals.
Use of funds
Establish commercial infrastructure for nationwide device access
Accelerate growth